Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idrabiotaparinux vs Warfarin for Stroke Prevention in Atrial Fibrillation
NCT00580216Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Dec 2007
- Primary completion
- Oct 2010
- Countries
- 48
01
Overview
A Phase 3 trial of idrabiotaparinux in Atrial fibrillation (AFib), sponsored by Sanofi. Started Dec 2007; status: terminated.
02
Drugs
idrabiotaparinux
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00580216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00580216.